Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
2025 "Study in Beijing" Education Exhibition Coming Soon to Vietnam and Indonesia! Face-to-face with Beijing's Top Universities – Unlock Your Study-Abroad Opportunities
BEIJING, Oct. 18, 2025 /PRNewswire/ — A news report from CRI Online…